ALL Video Channel
Explore the latest insights and summaries from experts in ALL.
Treatment Landscape
2024 ASCO® Annual Meeting Insights Hub
Understanding New Strategies to Prevent and Manage Chronic GVHD
FEATURING
Betty Hamilton
- 83 views
- June 16, 2024
- 1
SOHO Brazil 2024
How Are Targeted Therapies Redefining the Treatment Paradigm in ALL in Adults
FEATURING
Jan Burger
- 124 views
- July 11, 2024
- 1
University of Colorado Cancer Center
Frontline Treatment of ALL: Current Standards and Emergence of CAR-T
FEATURING
Marc Schwartz
- 69 views
- August 1, 2024
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
ALL in Adults: Overview and Recent Advances
FEATURING
Ryan Cassaday
- 242 views
- August 13, 2024
- 2
MyCancerHaven
Incorporating Blinatumomab and Inotuzumab Into 1L ALL Treatment
FEATURING
Ravi Vij,
Nicholas Short
- 167 views
- August 30, 2024
- 2
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: CML, AML, ALL
FEATURING
Mariam Nawas
- 45 views
- September 3, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in Ph+ ALL: Allo-SCT Is Not Necessary Upfront in Adult Patients
FEATURING
Elias Jabbour
- 44 views
- September 6, 2024
Talha Badar
Updates in ALL: Incorporating Immunotherapy in Frontline Management
- 275 views
- September 16, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 474 views
- September 23, 2024
- 2
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Incorporation of Targeted and Immunotherapies in ALL
FEATURING
Hagop Kantarjian
- 233 views
- August 30, 2024
- 1
Marlise R. Luskin
Treating Adult B-ALL: CAR-T vs. Bispecifics vs. Monoclonals
- 103 views
- October 21, 2024
- 2
ecancer
Transplantation in Adult ALL: Current Guidelines and Key Considerations
FEATURING
Sameer Tulpule
- 38 views
- October 30, 2024
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignancies
FEATURING
Ruemu Birhiray
- 925 views
- April 16, 2024
- 5
Indy Hematology Review
Treatment Strategies in MDS and ALL: Removing Bad Humor & Targeting Aberrant Signaling
FEATURING
Richard Stone
- 187 views
- April 22, 2024
MyCancerHaven
Treating Adults With Newly Diagnosed ALL
FEATURING
Ravi Vij,
Anand Patel
- 443 views
- April 26, 2024
- 4
Yale Cancer Center
Summary of Recent Advances in Adult ALL
FEATURING
Lourdes Mendez
- 138 views
- May 15, 2024
Rush University Medical Center
Selection and Sequencing of Chronic GVHD Therapy
FEATURING
Satyajit Kosuri
- 267 views
- May 24, 2024
- 1
Total Health
Fast Five Key Updates in Malignant Heme: Pearls From a Pharmacist
FEATURING
Sarah Medeiros
- 150 views
- November 26, 2024
- 2
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: ALL
FEATURING
Elias Jabbour
- 207 views
- March 29, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in Ph+ ALL: Allo-SCT Should Be Used Upfront in Adult Patients
FEATURING
Dieter Hoelzer
- 31 views
- September 6, 2024
Oncology 2024 Year in Review
Year in Review 2024 - Transformative FDA Approvals in Precision Oncology Across Various Cancer Types
FEATURING
Vivek Subbiah
- 299 views
- December 17, 2024
- 3
University of Illinois Cancer Center
Emerging Induction and Consolidation Regimens in ALL
FEATURING
John Quigley
- 1 view
- December 20, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Highlights in Adult ALL and Implications for Practice
FEATURING
Ryan Cassaday
- 149 views
- December 23, 2024
- 2